Finance & Investments
The Howard Hughes Medical Institute is the nation’s largest private supporter of academic biomedical research. As a medical research organization, the Institute must spend at least 3.5 percent of its endowment each year on direct medical research activities and related overhead, exclusive of grants and investment management expenses.
The endowment is the Institute’s principal source of funding. The investment objective is to manage the endowment in a prudent manner that will fund the Institute’s research and grants programs in perpetuity. On August 31, 2011, the endowment was approximately $16.1 billion.
Disbursements in Fiscal Year 2011
Disbursements during the fiscal year totaled $905 million, including $825 million for scientific research and $80 million for grants for science education. Over the past five years, disbursements by the Institute totaled over $4 billion.
HHMI’s research activities are conducted principally at Institute laboratories at medical centers, teaching hospitals and universities in the United States by investigators who hold faculty appointments at those host institutions. These individuals, together with their support staffs, are HHMI employees and are compensated directly by the Institute. Investigators may spend up to 25 percent of their time on teaching, administration, and other activities that benefit their institutions.
The Institute also conducts research at its Janelia Farm Research Campus in Loudoun County, Va., where Institute researchers are focused on identifying the general principles that govern how information is processed by neuronal circuits, and developing imaging technologies and computational methods for image analysis.
At the end of the fiscal year, the Institute employed more than 420 scientists at over 70 academic medical centers and Janelia Farm.
As of August 31, 2011, the Institute’s investment in laboratory space, equipment, and other property amounted to approximately $1.7 billion, with an estimated replacement value of $2 billion.
Through its grants program, the Institute supports science education at all levels, from the earliest grades through advanced research training. The Institute disbursed $70 million to support the activities of 419 grantees during fiscal year 2011.
Endowment and Financing
The Institute’s endowment is managed under the direction of its Vice President and Chief Investment Officer. Approximately 83 percent of the endowment is invested by external fund managers; the remainder is internally managed. External managers are used principally to manage alternative investments, including hedge funds, private equity, and derivatives.
At the close of fiscal year 2011, the endowment value was approximately $16.1 billion, an increase of $1.3 billion from the end of fiscal year 2010.
The composition of the Institute’s endowment by investment category on August 31, 2011, is reflected in the graph below
|Cash and Cash Equivalents||$||706||$||733|
|Investment and currency receivables, and other assets||326||182|
|Laboratory space, equipment, and other property—at cost, net of accumulated depreciation and amortization||855||867|
|Accounts payable, accrued expenses, and obligations||$||358||$||348|
|Investment purchases payable, repurchase obligations, short sales, and currency payables||706||544|
|Notes and bonds payable||1,323||1,323|
The Institute employs the firm of PricewaterhouseCoopers LLP as its independent auditor. The audited financial statements of the Institute for the year ended August 31, 2011, and the independent auditor’s report thereon are available on the Institute’s Web site at http://www.hhmi.org/about/financials, or they may be obtained by writing to:
Howard Hughes Medical Institute
4000 Jones Bridge Road
Chevy Chase, Maryland 20815-6789